Arecor Therapeutics (AREC) Share Price, News & Analysis

Company Overview

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com

Key Stats

• Today's Range: 42.03 to 43.50
• 50-Day Range: 36 to 45.15
• 52-Week Range: 35.40 to 125
• Volume: 19,529 shs
• Average Volume: 23,620 shs
• Market Capitalization: £16.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AREC Stock Analysis - Frequently Asked Questions

How have AREC shares performed this year?

Arecor Therapeutics' stock was trading at GBX 73.75 on January 1st, 2025. Since then, AREC stock has decreased by 42.4% and is now trading at GBX 42.50.
View the best growth stocks for 2025 here.

How were Arecor Therapeutics' earnings last quarter?

Arecor Therapeutics plc (LON:AREC) released its quarterly earnings data on Tuesday, April, 22nd. The company reported ($0.31) EPS for the quarter. Arecor Therapeutics had a negative trailing twelve-month return on equity of 118.67% and a negative net margin of 176.89%.

How do I buy shares of Arecor Therapeutics?

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Arecor Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Company Calendar

• Last Earnings: 4/22/2025
• Today: 6/18/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Coal
• Current Symbol: LON:AREC
• CIK: N/A
• Web: www.americanresourcescorp.com
• Phone: 44 1223 426 060
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (28.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£10.68 million
• Net Margins: -176.89%
• Pretax Margin: N/A
• Return on Equity: -118.67%
• Return on Assets: -37.31%

Debt

• Debt-to-Equity Ratio: 5.51
• Current Ratio: 1.37
• Quick Ratio: 6.24

Sales & Book Value

• Annual Sales: £6.04 million
• Price / Sales: 2.66
• Cash Flow: GBX 8.38 per share
• Price / Cash Flow: 5.07
• Book Value: GBX 16.58 per share
• Price / Book: 2.56

Miscellaneous

• Outstanding Shares: 37,756,599
• Free Float: N/A
• Market Cap: £16.05 million
• Optionable: Not Optionable
• Beta: -0.18